Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. logo
IONS

Ionis Pharmaceuticals, Inc. (IONS)

$38.983.32%

Market is closed
– opens on 8 PM, 06 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$38.8
Day's Range
$40.43
$26.41
52-Week Range
$48.82
1 month return6.32%
3 month return6.41%
1 year return41.75%
5 year return25.81%

Company Information

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Its scientific innovation began and continues with the knowledge that sick people depend on it, which fuels its vision of becoming one of the most successful biotechnology companies.
OrganizationIonis Pharmaceuticals, Inc.
Employees660
CEODr. Brett P. Monia Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 20 analysts ratings

Buy
55%
Buy
30%
Hold
15%
Sell

Based on 20 Wall street analysts offering stock ratings for Ionis Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 29.76%

Current

$38.98

Target

$50.58

Recommendation Trend

Based on 20 analyst

Current1M Ago3M Ago
Buy
11
17
16
Hold
6
6
7
Sell
3
5
5
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
5.7B
Book Value
$4.18
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
0.07
PE Ratio
573.86
PEG Ratio
25.7
Wall Street Target Price
50.58

Valuation

Trailing PE573.86
Forward PE90.91
Price/Book (mrq)
9.64
Enterprise Value
5.0B
Enterprise Value/Revenue
5.68
Enterprise Value/Ebitda
144.39

Technicals

Beta
0.55
50 Day MA
43.71
200 Day MA
39.88

Sustainability

Rating Date2019-01-01
Total Esg
36.64
Total Esg Percentile
62.18
Environment Score5.18
Environment Score Percentile9.0
Social Score26.17
Social Score Percentile9.0
Governance Score13.29
GovernanceScorePercentile9.0
Controversy Level0.0

Institutional Holdings

FMR Inc

14.97%

Vanguard Group Inc

9.02%

Bellevue Group AG

6.66%

BlackRock Inc

6.29%

ClearBridge Advisors, LLC

4.23%

T. Rowe Price Associates, Inc.

3.38%

Discover more

Frequently Asked Questions

What is Ionis Pharmaceuticals, Inc. share price today?

Can Indians buy Ionis Pharmaceuticals, Inc. shares?

How can I buy Ionis Pharmaceuticals, Inc. shares from India?

Can Fractional shares of Ionis Pharmaceuticals, Inc. be purchased?

What are the documents required to start investing in Ionis Pharmaceuticals, Inc. stocks?

What are today’s High and Low prices of Ionis Pharmaceuticals, Inc.?

What are today’s traded volumes of Ionis Pharmaceuticals, Inc.?

What is today’s market capitalisation of Ionis Pharmaceuticals, Inc.?

What is the 52 Week High and Low Range of Ionis Pharmaceuticals, Inc.?

How much percentage Ionis Pharmaceuticals, Inc. is down from its 52 Week High?

How much percentage Ionis Pharmaceuticals, Inc. is up from its 52 Week low?

What are the historical returns of Ionis Pharmaceuticals, Inc.?

Who is the Chief Executive Officer (CEO) of Ionis Pharmaceuticals, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*